» Articles » PMID: 16242293

A Literature Review of the Psychological Impact of Genetic Testing on Breast Cancer Patients

Overview
Publisher Elsevier
Specialties Health Services
Nursing
Date 2005 Oct 26
PMID 16242293
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Easier access and increased awareness results in more referral for genetic testing for hereditary breast cancer in healthy at-risk women and breast cancer patients. To investigate the psychological impact of genetic testing on breast cancer patients, literature pertaining to this group was reviewed.

Method: Medline and PsychInfo databases were searched over the period 1995-2004 for studies aimed at breast cancer patients referred for genetic testing. Qualitative and quantitative psychological outcome measures were identified.

Results: Eight papers were identified focusing on women affected by breast cancer and undergoing genetic counseling and DNA testing.

Conclusion: Genetic testing does not lead to an increase in psychological distress in breast cancer patients. However, a recent breast cancer diagnosis adds to general and cancer-specific distress prior to genetic counseling and after DNA test disclosure.

Practice Implications: Clinicians need to be aware of possible high psychological distress and additional counseling needs of recently diagnosed breast cancer patients taking part in genetic testing. Further research should focus on patients who decline genetic counseling or receive an inconclusive test result, including age upon and time since diagnosis.

Citing Articles

The Evolution of Genetic Testing from Focused Testing to Panel Testing and from Patient Focused to Population Testing: Are We There Yet?.

Gima L, Solomon I, Hampel H Clin Colon Rectal Surg. 2024; 37(3):133-139.

PMID: 38606045 PMC: 11006441. DOI: 10.1055/s-0043-1770381.


The dynamic buffering of social support on depressive symptoms and cancer worries in patients seeking cancer genetic counseling.

Ho S, Palka J, Mersch J, Martin W, Howe-Martin L J Cancer Surviv. 2024; .

PMID: 38512562 DOI: 10.1007/s11764-023-01479-x.


The ENGAGE study: a 3-arm randomized hybrid type 1 effectiveness and implementation study of an in-home, collaborative PCP model of remote telegenetic services to increase uptake of cancer genetic services in childhood cancer survivors.

Henderson T, Allen M, Mim R, Egleston B, Fleisher L, Elkin E BMC Health Serv Res. 2024; 24(1):253.

PMID: 38414045 PMC: 10900774. DOI: 10.1186/s12913-024-10586-z.


REFUTING THE RIGHT NOT TO KNOW.

Berkman B J Health Care Law Policy. 2023; 19(1):1-72.

PMID: 37033891 PMC: 10078625.


What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing.

Frey M, Ahsan M, Badiner N, Lin J, Narayan P, Nitecki R Cancer. 2022; 128(24):4241-4250.

PMID: 36305018 PMC: 10041659. DOI: 10.1002/cncr.34482.